CHRM2 and schizophrenia: In the striatum, it has been reported that levels of [3H]pirenzepine binding (Dean et al., 1996) but not CHRM1 or CHRM2 mRNA (Dean et al., 2000), were lower in people with schizophrenia compared to controls.